Human recombinant ENA 78/CXCL5 (from E. coli)

Lieferant: Shenandoah Biotechnology

100-185-100UG 100-185-1MG 100-185-20UG 100-185-500UG 100-185-5UG
SHBT100-185-100UGEA 544 CHF
SHBT100-185-100UG SHBT100-185-1MG SHBT100-185-20UG SHBT100-185-500UG SHBT100-185-5UG
Human recombinant ENA 78/CXCL5 (from E. coli)
Proteine und Peptide

Epithelial-derived neutrophil-activating peptide 78 (ENA 78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis.


  • Produced from genetically modified E. coli
  • Stimulates connective tissue remodelling
  • Monomeric protein, contains 74 amino acids


ENA 78 production is stimulated by interleukin 1 (IL-1) or tumor necrosis factor alpha (TNFα), and signals through the chemokine receptor CXCR2.


ENA 78, 5-78 aa is one of three naturally occurring ENA 78 variants in which the N-terminus has been truncated.


Lieferumfang: A Certificate of Analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.


Bitte beachten This product is for research use only and is not for use in humans.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR